There are challenges to expanding measurement-based care into behavioral health, as much of the data are self-reported and can be difficult to track
For most people with CKD stages 1 to 3, yes
Industry insiders believe that Merck's increased investment in the GLP-1 space is closely tied to the performance pressure it faces
Whether youre managing hypothyroidism, navigating hormone replacement therapy (HRT), or exploring GLP-1 medications for metabolic support, we know that the road to better health can be complex
In the following sections, we cover a few urolithin A alternatives
As a glucagon-like peptide 1 (GLP-1) receptor agonist, it lowers hunger stimulation in several areas of the brain, which reduces your food intake